Rosa Rodríguez-Fernández

Rosa Rodríguez-Fernández

Auto-generated profile, based on publicly available information

Rosa Rodríguez-Fernández

Hospital Internal Pediatrics Section, Children's Hospital, Gregorio Marañón General Hospital, Madrid, Spain

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2024 in Revista Española de Quimioterapia
Verified
Journal Article
Open access
JRJulián Ruiz-Galiana
Julián Ruiz-Galiana
RCRafael Canton
Rafael Canton
PRPilar de Lucas Ramos
Pilar de Lucas Ramos
AGAlejandra García-Botella
Alejandra García-Botella
Alberto García-LledoAlberto García-Lledo
Alberto García-Lledo
EBEmilio Bouza
Emilio Bouza
Respiratory syncytial virus (RSV) is a major public health problem that has undergone significant changes in recent years. First of all, it has become easier to diagnose with highly reliable and rapidly available confirmatory tests. This has led to a better understanding of its epidemiology and RSV has gone from being a disease of the pediatric age group, severe only in infants and immunosuppressed children, to being a common disease in people of all ages, particularly important in patients of advanced age or with immunosuppressive diseases. Recent therapeutic and prophylactic advances, both with long-lasting monoclonal antibodies and vaccines, are another reason for satisfaction. For these reasons, the COVID and Emerging Pathogens Committee of the Illustrious Official College of Physicians of Madrid (ICOMEM) has considered it pertinent to review this subject in the light of new knowledge and new resources for dealing with this infection. We have formulated a series of questions that we believe will be of interest not only to members of the College but also to any non-expert in this subject, with a particular focus on the situation of RSV infection in Spain.

14 July 2022 in Journal of Allergy and Clinical Immunology: Global
Verified
Journal Article
Open access
RRRosa Rodriguez-Fernandez
Rosa Rodriguez-Fernandez
MGMaría Isabel González-Sánchez
María Isabel González-Sánchez
JPJimena Perez-Moreno
Jimena Perez-Moreno
FGFelipe González-Martínez
Felipe González-Martínez
SNSara de la Mata Navazo
Sara de la Mata Navazo
OROctavio Ramilo
Octavio Ramilo
Respiratory syncytial virus (RSV) is the most frequent cause of bronchiolitis. Precise and updated information about demographic characteristics, clinical manifestations, and risk factors for severe disease are needed for optimal implementation of upcoming new therapeutic and preventive interventions. The main goals of this study were to define the epidemiology of acute bronchiolitis in hospitalized young children during 5 calendar years in Spain; evaluate the differences in clinical manifestations between children hospitalized with RSV infection and those hospitalized with non-RSV infection; and identify demographic characteristics, clinical parameters, and risk factors associated with disease severity. We performed a retrospective review of the medical records of children younger than 2 years who were hospitalized with bronchiolitis between January 2015 and December 2019. We constructed multivariable models to identify independent predictors of disease severity defined as length of hospital stay (LOS), pediatric intensive care unit (PICU) admission, and need for a high-flow-nasal canula (HFNC). From January 2015 to December 2019, 1437 children were hospitalized with bronchiolitis and met the inclusion criteria. The proportion of children hospitalized with bronchiolitis caused by RSV increased significantly during the study period, from 60% to 65% (P = .03). The children with RSV bronchiolitis were younger than those with non-RSV bronchiolitis (median age = 3 months [interquartile range = 1.5-6.5 months] vs 4 months [interquartile range = 2-7.5 months], respectively (P < .01). The children younger than 6 months with RSV bronchiolitis had enhanced disease severity compared with those with non-RSV bronchiolitis, as defined by an LOS of more than 4 days, severity scores, need for an HFNC, intravenous fluids, enteral feeding, and PICU admissions (P < .01). Age younger than 6 months and RSV-positive etiology were independently associated with greater odds of PICU admission, need for an HFNC, and longer LOS. This study identified differences in disease severity between young children with RSV bronchiolitis and those with non-RSV bronchiolitis. These differences are particularly significant in children younger than 6 months, who comprise a group of infants with suboptimal innate immunity to RSV and may benefit from new preventive strategies.

4 September 2023 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
RRRosa Rodriguez-Fernandez
Rosa Rodriguez-Fernandez
FGFelipe González-Martínez
Felipe González-Martínez
JPJimena Perez-Moreno
Jimena Perez-Moreno
MGMaría Isabel González-Sánchez
María Isabel González-Sánchez
BCBlanca Toledo del Castillo
Blanca Toledo del Castillo
OROctavio Ramilo
Octavio Ramilo
We analyzed the frequency, clinical impact and severity of respiratory syncytial virus (RSV) and SARS-CoV-2 coinfections in a single pediatric center between March 2020 and January 2023. Compared to single RSV infections, RSV/SARS-CoV-2 coinfections were uncommon (2.1%), occurred more frequently during circulation of omicron, and were associated with increased disease severity as defined by longer hospitalization and increased need for high-flow nasal cannula.

21 December 2022 in American Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
RRRosa Rodríguez-Fernández
Rosa Rodríguez-Fernández
FGFelipe González-Martínez
Felipe González-Martínez
JPJimena Perez-Moreno
Jimena Perez-Moreno
MGMaría Isabel González-Sánchez
María Isabel González-Sánchez
SNSara de la Mata Navazo
Sara de la Mata Navazo
OROctavio Ramilo
Octavio Ramilo
Objective The main objective of this report was to comprehensively analyze the clinical characteristics of children hospitalized with respiratory syncytial virus (RSV) infections in 2021 during the coronavirus disease 2019 (COVID-19) pandemic and to compare them with those in the five previous RSV seasons. We hypothesized that the clinical and demographic features of children hospitalized with RSV infection in 2021 were different from those hospitalized in previous respiratory seasons. Study Design In this retrospective observational study, children younger than 2 years hospitalized with RSV bronchiolitis from January 1, 2015, to December 31, 2021, at the Department of Pediatrics of the Hospital Gregorio Marañón, Madrid, Spain, were included. We compared the clinical characteristics of children hospitalized with RSV bronchiolitis in the five seasons before the COVID-19 pandemic and during the subsequent off-seasonal surge of RSV infections. Results We found a significant reduction in hospitalizations for RSV bronchiolitis during the usual winter epidemic period due to the COVID-19 pandemic. Children hospitalized with RSV infection in 2021, during the COVID-19 pandemic, were older than children hospitalized in the prepandemic period (2015–2020; 4.0 [1.6–9.2] vs. 3 [1.5–6.5] months; p < 0.01). We also found shorter duration of oxygen days during the COVID-19 period compared with previous respiratory seasons (3 [2–5] vs. 4 [2–6] days; p = 0.02). Conclusion The COVID-19 pandemic modified the RSV seasonality with a significant reduction in RSV hospitalizations during the expected 2020–2021 season and a reappearance of RSV 7 months later than expected. We also found changes in the median age of children with RSV bronchiolitis during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic compared with the prepandemic RSV seasons and shorter duration of oxygen days suggesting a modest reduction in disease severity. We hypothesize that this observation reflects the lack of RSV circulation in the previous months (April 2020-March 2021), with a larger pool of vulnerable infants that had not been previously infected. Key Points

24 November 2006 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
OAO A Adelola
O A Adelola
RFR Fernandez
R Fernandez
RARiaz Ahmad
Riaz Ahmad
MLM Leamy
M Leamy
BMB G Moriarty
B G Moriarty
External ear manifestations of sarcoidosis are rare. We review six cases in the literature and also report a case. The otolaryngologist plays an important role in making the diagnosis because of the ease of biopsy in all cases of sarcoidosis of the external ear.

1 April 2021 in Cytokine
Verified
Journal Article
Closed access
RRRosa Rodríguez-Fernández
Rosa Rodríguez-Fernández
FGFelipe González-Martínez
Felipe González-Martínez
MGMaría Isabel González-Sánchez
María Isabel González-Sánchez
THTeresa Hernández-Sampelayo
Teresa Hernández-Sampelayo
JJJose Luis Jimenez
Jose Luis Jimenez
OROctavio Ramilo
Octavio Ramilo